Also written by Finanzen.Net Gmbh:
A Bidding War for 21st Century Fox Could Break Out — Here's How it Got to that Point
x hide permanently

Abbvie is Buying Botox-Maker Allergan in a $63 Billion Pharma Mega-Deal

Stock Market Data Today
  • AbbVie has agreed to buy Allergan in a $63 billion cash-and-stock deal.
  • Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they hold, totaling $188.24 per Allergan share.
  • The offer represents a 45% premium to the closing price of Allergan's shares on Wednesday...
Mentions: Wall Street Allergan CEO